Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials



Andes, David R, Ghannoum, Mahmoud A, Mukherjee, Pranab K, Kovanda, Laura L ORCID: 0000-0002-4493-4652, Lu, Qiaoyang, Jones, Mark E, Henriksen, Anne Santerre, Lademacher, Christopher and Hope, William W ORCID: 0000-0001-6187-878X
(2019) Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 63 (1).

Access the full-text of this item by clicking on the Open Access link.
Item Type: Article
Uncontrolled Keywords: MIC, clinical trial, isavuconazole, isavuconazonium sulfate, voriconazole
Depositing User: Symplectic Admin
Date Deposited: 17 Jan 2019 11:12
Last Modified: 07 Nov 2020 10:10
DOI: 10.1128/AAC.01634-18
Open Access URL: https://aac.asm.org/content/63/1/e01634-18
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3031429